Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shengchun Liu

Showing results (111-120 of 142) with videos related to

Pageof 15
Sort By:
Oncology Reports|July 23, 2021
[Corrigendum] HORMAD1 promotes docetaxel resistance in triple negative breast cancer by enhancing DNA damage toleranceBeige Zong, Lu Sun, Yang Peng, et al.
Journal of Personalized Medicine|February 25, 2023
Nomograms for Predicting Disease-Free Survival Based on Core Needle Biopsy and Surgical Specimens in Female Breast Cancer Patients with Non-Pathological Complete Response to Neoadjuvant ChemotherapyAilin Lan, Han Li, Junru Chen, et al.
ACS Sensors|July 22, 2025
Integrated Fiber-Optic SPR Sensor with Cyclone Sampling for Rapid On-Site Bioaerosol Pathogen DetectionShiyu Jiang, Siyu Qian, Ying Guo, et al.
Journal of Oncology|September 5, 2022
Prognostic Signature and Therapeutic Value Based on Membrane Lipid Biosynthesis-Related Genes in Breast CancerYingkun Xu, Yudi Jin, Shun Gao, et al.
Frontiers in Surgery|September 19, 2022
Association of serum reproductive hormones changes after neoadjuvant chemotherapy with hormone receptors expression alterations and survival outcomes in breast cancerAilin Lan, Yudi Jin, Yu Wang, et al.
Journal of Oncology|September 19, 2022
Cuprotosis-Related Genes: Predicting Prognosis and Immunotherapy Sensitivity in Pancreatic Cancer PatientsYingkun Xu, Han Li, Ailin Lan, et al.
Nucleic Acids Research|October 29, 2025
GPSAdb 2.0: an expanded atlas of gene-perturbation transcriptomes with enhanced tools for regulatory gene discoveryShipeng Guo, Yanshuang Jiang, Jieya Zou, et al.
International Journal of Clinical Oncology|March 3, 2022
Pre-treatment circulating reproductive hormones levels predict pathological and survival outcomes in breast cancer submitted to neoadjuvant chemotherapyAilin Lan, Yudi Jin, Yu Wang, et al.
International Journal of Oncology|April 23, 2020
Although c‑MYC contributes to tamoxifen resistance, it improves cisplatin sensitivity in ER‑positive breast cancerRui Chen, Shipeng Guo, Chengcheng Yang, et al.
Oncology Reports|May 26, 2021
HORMAD1 promotes docetaxel resistance in triple negative breast cancer by enhancing DNA damage toleranceBeige Zong, Lu Sun, Yang Peng, et al.
Pageof 15

Showing results (111-120 of 142) with videos related to

Sort By:
Pageof 15
Oncology Reports|July 23, 2021
[Corrigendum] HORMAD1 promotes docetaxel resistance in triple negative breast cancer by enhancing DNA damage toleranceBeige Zong, Lu Sun, Yang Peng, et al.
Journal of Personalized Medicine|February 25, 2023
Nomograms for Predicting Disease-Free Survival Based on Core Needle Biopsy and Surgical Specimens in Female Breast Cancer Patients with Non-Pathological Complete Response to Neoadjuvant ChemotherapyAilin Lan, Han Li, Junru Chen, et al.
ACS Sensors|July 22, 2025
Integrated Fiber-Optic SPR Sensor with Cyclone Sampling for Rapid On-Site Bioaerosol Pathogen DetectionShiyu Jiang, Siyu Qian, Ying Guo, et al.
Journal of Oncology|September 5, 2022
Prognostic Signature and Therapeutic Value Based on Membrane Lipid Biosynthesis-Related Genes in Breast CancerYingkun Xu, Yudi Jin, Shun Gao, et al.
Frontiers in Surgery|September 19, 2022
Association of serum reproductive hormones changes after neoadjuvant chemotherapy with hormone receptors expression alterations and survival outcomes in breast cancerAilin Lan, Yudi Jin, Yu Wang, et al.
Journal of Oncology|September 19, 2022
Cuprotosis-Related Genes: Predicting Prognosis and Immunotherapy Sensitivity in Pancreatic Cancer PatientsYingkun Xu, Han Li, Ailin Lan, et al.
Nucleic Acids Research|October 29, 2025
GPSAdb 2.0: an expanded atlas of gene-perturbation transcriptomes with enhanced tools for regulatory gene discoveryShipeng Guo, Yanshuang Jiang, Jieya Zou, et al.
International Journal of Clinical Oncology|March 3, 2022
Pre-treatment circulating reproductive hormones levels predict pathological and survival outcomes in breast cancer submitted to neoadjuvant chemotherapyAilin Lan, Yudi Jin, Yu Wang, et al.
International Journal of Oncology|April 23, 2020
Although c‑MYC contributes to tamoxifen resistance, it improves cisplatin sensitivity in ER‑positive breast cancerRui Chen, Shipeng Guo, Chengcheng Yang, et al.
Oncology Reports|May 26, 2021
HORMAD1 promotes docetaxel resistance in triple negative breast cancer by enhancing DNA damage toleranceBeige Zong, Lu Sun, Yang Peng, et al.
Pageof 15